Several of the 78 DElncRNAs we found have documented roles in other cancers, such as EXOC3-AS1, which has been reported to be upregulated in lung cancer patients [54,55]; INHBA-AS1, proposed to be part of a diagnostic marker in gastric cancer [56] and proven to promote CRC via sponging miR-422a [57]; and CRYM-AS1, associated with the overall survival of thyroid cancer patients [58] and identified as a potential tumor suppressor in gastric cancer, due to its negative regulation of CRYM [59]. The gene discussed is CRYM; the disease is lung cancer.